974 results on '"Lesnick, Timothy G."'
Search Results
202. Confirmation of 123I-FP-CIT-SPECT (ioflupane) quantification methods in Dementia with Lewy Body and other neurodegenerative disorders.
203. Confirmation of 123I-FP-CIT-SPECT (ioflupane) quantification methods in Dementia with Lewy Body and other neurodegenerative disorders.
204. Association of Apolipoprotein E ε4 With Transactive Response DNA-Binding Protein 43
205. Development of a cerebrovascular magnetic resonance imaging biomarker for cognitive aging
206. IC‐P‐019: LONGITUDINAL ACCUMULATION OF β‐AMYLOID ON PET IN DEMENTIA WITH LEWY BODIES AND RELATIONSHIP TO CLINICAL DISEASE PROGRESSION
207. O2‐13‐06: PITTSBURGH COMPOUND‐B BINDING IN WHITE MATTER HYPERINTENSITIES IS ASSOCIATED WITH LOSS OF WHITE MATTER INTEGRITY ON DTI
208. P3‐424: LONGITUDINAL ACCUMULATION OF β‐AMYLOID ON PET IN DEMENTIA WITH LEWY BODIES AND RELATIONSHIP TO CLINICAL DISEASE PROGRESSION
209. O2‐13‐01: INCIDENCE OF CEREBRAL MICROBLEEDS AND AMYLOID BURDEN: THE MAYO CLINIC STUDY OF AGING
210. P3‐597: MEDIAL TEMPORAL LOBE NEURODEGENERATION OBSERVED IN WOMEN WHO UNDERWENT BILATERAL OOPHORECTOMY BEFORE THE ONSET OF MENOPAUSE
211. P1‐420: ACCELERATED NEUROCHEMICAL CHANGES PRIOR TO PHENOCONVERSION TO FRONTOTEMPORAL LOBAR DEGENERATION IN PRESYMPTOMATIC MICROTUBULE‐ASSOCIATED PROTEIN TAU (MAPT) MUTATION CARRIERS: A LONGITUDINAL MRS STUDY
212. P4‐236: STRUCTURAL EQUATION MODELLING REVEALS A DIRECT AND INDIRECT EFFECT OF APOE ε4 ON TAR DNA BINDING PROTEIN 43
213. Microinfarcts and blood pressure trajectories: response to Dr Niu et al.
214. Brain structure and cognition 3 years after the end of an early menopausal hormone therapy trial
215. Association Between Microinfarcts and Blood Pressure Trajectories
216. Diffusion models reveal white matter microstructural changes with aging, pathology, and cognition.
217. Predicting survival in Dementia with Lewy Bodies with hippocampal volumetry
218. Regional cortical perfusion on arterial spin labeling MRI in dementia with Lewy bodies: Associations with clinical severity, glucose metabolism and tau PET
219. Longitudinal Association Between Brain Amyloid-Beta and Gait in the Mayo Clinic Study of Aging
220. Influence of preeclampsia and late-life hypertension on MRI measures of cortical atrophy
221. Age, vascular health, and Alzheimer disease biomarkers in an elderly sample
222. 1H-MRS metabolites and rate of β-amyloid accumulation on serial PET in clinically normal adults
223. CEREBRAL MICROBLEEDS AND AMYLOID BURDEN: THE MAYO CLINIC STUDY OF AGING
224. [P3-343]: INVESTIGATION OF PITTSBURGH COMPOUND-B BINDING IN WHITE MATTER HYPERINTENSITIES
225. CHANGES IN BRAIN STRUCTURE THREE YEARS AFTER THE END OF MENOPAUSAL HORMONE THERAPIES IN A RANDOMIZED CONTROLLED TRIAL
226. [IC-P-021]: INVESTIGATION OF PITTSBURGH COMPOUND-B BINDING IN WHITE MATTER HYPERINTENSITIES
227. [IC-P-075]: PATTERN OF HYPOPERFUSION ON ASL OVERLAPS WITH HYPOMETABOLISM ON FDG-PET IN DEMENTIA WITH LEWY BODIES
228. [P1-457]: LONGITUDINAL ASSOCIATIONS BETWEEN CEREBRAL AMYLOID DEPOSITION, CORTICAL THICKNESS, AND GAIT IN THE MAYO CLINIC STUDY OF AGING
229. [P1-393]: PATTERN OF HYPOPERFUSION ON ASL OVERLAPS WITH HYPOMETABOLISM ON FDG-PET IN DEMENTIA WITH LEWY BODIES
230. Decreased Glutamate Levels in Patients with Amnestic Mild Cognitive Impairment: An sLASER Proton MR Spectroscopy and PiB-PET Study
231. Evaluation of Amyloid Protective Factors and Alzheimer Disease Neurodegeneration Protective Factors in Elderly Individuals
232. Pittsburgh compound-B PET white matter imaging and cognitive function in late multiple sclerosis
233. Pittsburgh compound-B PET and MRI biomarkers of cognition in aging MS patients (P4.347)
234. Advanced 1H-MRS detects decreased glutamate levels in amnestic MCI (P4.093)
235. Aortic hemodynamics and white matter hyperintensities in normotensive postmenopausal women
236. Abstract WMP57: Declining Blood Pressure is Associated with Subcortical Microinfarcts in Older Adults
237. Testing the brain maintenance and cognitive reserve hypothesis of cognitive aging: Application to vascular and metabolic risk factors.
238. β-Amyloid PET and neuropathology in dementia with Lewy bodies.
239. Cardiometabolic Health and Longitudinal Progression of White Matter Hyperintensity: The Mayo Clinic Study of Aging.
240. 18 F-AV-1451 uptake differs between dementia with lewy bodies and posterior cortical atrophy.
241. ANALYSIS OF IOFLUPANE-SPECT FINDINGS USING DATQUANT IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT
242. ANALYSIS OF IOFLUPANE-SPECT FINDINGS USING DATQUANT IN PATIENTS WITH IDIOPATHIC REM SLEEP BEHAVIOR DISORDER
243. RELATIONSHIP BETWEEN MIDLIFE FACTORS AND MULTIMODAL IMAGING MEASURES OF NEUROBIOLOGICAL CAPITAL: MAYO CLINIC STUDY OF AGING
244. BIOMARKERS FOR CAPTURING AMYLOID-INDEPENDENT EFFECTS OF VASCULAR HEALTH ON COGNITIVE DECLINE
245. PATHOLOGIC ASSOCIATIONS OF FDG PET IN LEWY BODY DISEASE
246. TRAJECTORY OF LOBAR ATROPHY IN ASYMPTOMATIC AND SYMPTOMATIC GRN MUTATION CARRIERS: A LONGITUDINAL TBM-SYN STUDY
247. SLEEP QUALITY AND BETA-AMYLOID DEPOSITION IN RECENTLY MENOPAUSAL WOMEN PARTICIPATING IN THE KRONOS EARLY ESTROGEN PREVENTION STUDY (KEEPS)
248. MILD COGNITIVE IMPAIRMENT PROGRESSING TO DEMENTIA WITH LEWY BODIES: REGIONAL ATROPHY RATES AND RELATIONSHIP TO AV-1451 UPTAKE
249. ASSOCIATIONS OF PITUITARY-OVARIAN HORMONES AND BRAIN STRUCTURE IN RECENTLY MENOPAUSAL WOMEN USING HORMONE THERAPY
250. RATES OF LOBAR ATROPHY IN ASYMPTOMATIC MAPT MUTATION CARRIERS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.